AAPL |
$AAPL BULLISH CWEB BUSINESS News: Appleâs iPhone Sales Jump May Fade as UBS Warns of Short-Lived Demand Surge https://cweb.com/cweb-business-news-apples-iphone-sales-jump-may-fade-as-ubs-warns-of-short-lived-demand-surge/ |
180202 |
TSLA |
$TSLA $EBAY $WMT $GOOGL BULLISH CWEB Exclusive: Elon Musk-Led Tesla Launches Robotaxi in Austin â Early Riders Get Exclusive $4.20 Flat Fare https://cweb.com/cweb-exclusive-elon-musk-led-tesla-launches-robotaxi-in-austin-early-riders-get-exclusive-4-20-flat-fare/ |
180202 |
GME |
Must ... fill ... gap
Must ... fill ... gap
Must ... fill ... gap
Must ... fill ... gap
Must ... fill ... gap
Must ... fill ... gap
Must...
$GME |
62572 |
AMD |
đ $AMD has completed correction as Zig Zag and is now rallying in a bullish sequence. Elliott Wave points to higher targets ahead!
đ https://elliottwave-forecast.com/stock-market/amd-elliott-wave-bullish-sequences/
#AMD #trading #elliottwave #stockmarket |
47491 |
MU |
My report for $UPST -- "the company Starting its move Up" has officially been released.
đ access these reports via link in my bio for just $18 using the promo code, and navigate to the #play-blueprint tab on discord.
You can also find reports on the stocks below which were released previously at time of their core entries.
$MU $U $HOOD $DDOG |
20474 |
HOOD |
Just a reminder that just because $HOOD is trading right at all time highs doesnât make it more âexpensiveâ than other competitors
You donât always need to find a âsympathyâ for something when even the leader itself is still greatly undervalued. The market will still continue to buy up Robinhood for this exact reason and not other sympathies |
20472 |
UPST |
$UPST
this report will officially go live at 5pm ET today
thank you very much |
20470 |
AMAT |
$AMAT below 150 in play âŚ. |
18467 |
AZ |
$AZ $373M mc FOUNDER-LED đ $XLY + $XLK retail technology name breaking out to 3-year highs & closing above key $10 level on volume off the rising 10-week SMA đ
- Pct of all funds long at record highs following a huge jump in the most recent qtr
TrendEdge.app/asset/AZ |
17931 |
NN |
$NN $1.87B mc FOUNDER-LED đ $XLK name and Short Squeeze screen results breaking out on volume above freshly rising 10/40/80-week SMAs
- Short float % topped out and is trending lower đĽđ
- Pct of all funds long at record highs & rising đŚ
TrendEdge.app/asset/NN |
17931 |
AWI |
$AWI $6.73B mc $XLI Hidden Gem (just 194 watchers on Stocktwits, unreal!) with an accumulation week off rising 10-week SMA above rising 40/80-week SMAs... đď¸ââď¸
- Pct of all funds rose significantly in the most recent qtr to fresh record highs of 4.91%
- $200 đ§˛
TrendEdge.app/asset/AWI |
17931 |
BBIO |
$BBIO $7.8B mc FOUNDER-LED đ $XBI leader breaking out thru key $40 level above freshly rising 10/40/80-week SMAs into 3.5-year highs
- Pct of all funds at record highs and rising
- Short float % rolling over
- Significant RS to industry
TrendEdge.app/asset/BBIO |
17931 |
LTH |
$ATAT easily number one. $4.1B mc founder-led $XLY name high-and-tight at ATHs outside of 2-year IPO base. Pct of all funds at record highs & rising. cc $LTH the US version |
17931 |
CCK |
$CCK $12.25B mc $XLY recyclable packaging solutions Hidden Gem (just 439 watchers on Stocktwits) quietly breaking out through key $100 level on volume into 3-year highs
- Pct of all funds jumped to 3-year highs in the most recent qtr đ
- Short float % quickly rolling over the past 2-months from 6% highs
TrendEdge.app/asset/CCK |
17931 |
BKSY |
$BKSY $382M mc $XLK space-based geospatial tech and analytics name seeing ramping weekly volume as price pushes off freshly rising 10/40/80-Week SMAs đđ°ď¸
- Pct of all funds long at record highs & rising đŚ
- Short float % also high and rising so keep an eye on that, would like to see it come down â ď¸
TrendEdge.app/asset/BKSY |
17931 |
TKO |
$TKO $14.4B mkt cap $XLC sports entertainment stock nearing all-time highs with renewed accumulation off 10-week SMA.
- Pct of funds long at record highs and rising.
- Short float Pct trending lower from 10%+ highs three months ago
- Significant insider buying this year, including a $166k unplanned open market purchase by a director two weeks ago
TrendEdge.app/asset/TKO |
17931 |
ZS |
$DT $16.56B mc FOUNDER-LED đ $XLK name seeing accumulation as price build a base above rising 40-week SMA. Reminds me of $ZS before breakout
- Pct of all funds quietly made a record highs in the most recent qtr
- Short float % in the gutter in the gutter near record lowsđ
TrendEdge.app/asset/DT |
17931 |
AAPL |
$AAPL $QQQ $SPY đŻ facts |
16876 |
AMD |
$INTC $AMD $NVDA War is not fun, but when we are dealing with the reality, we must still locate tradesâŚ. Chips are being used up each explosion every day so the obvious play is chip stocks as these chips and more need to be replenished! Be safe- pray for cooler heads and better outcomes for all- and stack gains |
16876 |
AAPL |
$AAPL $QQQ $INTC Markets likely green Monday. More certainty than uncertainty at this point now |
16874 |
ALT |
$ALT All I need to see, See you over 20+ soon |
15848 |
NVDA |
$SPY
19 US bases in the middle east are at risk now. China will cut ties with the USA. Strait of Hormuz closes. Economy implodes $QQQ $AAPL $NVDA |
15641 |
AAPL |
$SPY Crude oil+7% $QQQ $AAPL $BTC.X |
15641 |
AAPL |
$SPY Hormuz closes and black Monday $QQQ $AAPL $TSLA |
15641 |
AAPL |
$SPY horrible just horrible $QQQ $TSLA $AAPL $BTC.X |
15641 |
NVDA |
$CGBS we are trendinggg!! insane bombing today on Iran! Watching $NVDA $TSLA $GME $SPY |
15468 |
TSLA |
$CGBS oil might hit over $100 Monday oil tickers about to go to new new highs! Watching $SPY $NVDA $TSLA $GME |
15468 |
AMZN |
$AMZN https://chrisdemuthjr.medium.com/make-200-in-15-seconds-36259cb69357 |
13702 |
AKBA |
$AKBA is it August yet! đĽ |
9169 |
AKBA |
$AKBA This is great news for upcoming NDD Aprroval of Vafseo!
https://apnews.com/article/fda-drugs-makary-trump-accelerated-approval-752146d97521b1644c9b10f2c6361f33#:~:text=Food%20and%20Drug%20Administration%20Commissioner,reviews%20take%20about%2010%20months. |
9169 |
MSTR |
$BTC.X somewhere
Michael Saylor is buying the dip
$mstr. |
8198 |
RTX |
đ JOIN THE $7 SWING TRADING CLUB đ
đĽ Your edge in this market starts here! đĽ
â
Weekly Top 5 Swing Picks
â
Private Chat Access
â
Live Market Updates
â
Daily Watchlist Hub
â
Entries & Targets Mapped Out
đŻ Whether youâre part-time or all-in, we make it simple, sharp, and profitable.
đ http://pennybo.is/swing-scout-gold-weekly đ
$SPY $AAPL $USO $RTX $TSLA |
7767 |
SYNX |
$SYNX đhugeđ #1 đĽđ¤Ť
đŻ%+ Mondayđđđđđđ
All my followers are making bank đŚ
You all gonna be rich đ¤đđđđđ¤ |
7642 |
PET |
Monday fire đĽlistđĽ
$SYNX đ
$DHAI
$PET
$HCTI
$CDT
To the moonđđđđđđ
All my followers are making bank đŚ
You all gonna be rich đ¤ |
7638 |
USEG |
Monday oil listđĽđĽ
$EONR
$USEG
$GURE
$GBR
$TPET
To the moonđđđđđđ
All my followers are making bank đŚ
You all gonna be rich đ¤ |
7638 |
DFLI |
Monday oil list 2 đĽđĽ
$HUSA
$INDO
$CGBS
$DFLI
$RBNE
To the moonđđđđđđ
All my followers are making bank đŚ
You all gonna be rich đ¤ |
7638 |
SYNX |
$SYNX đ
Monday đđđđđđđđđ |
7629 |
SYNX |
$SYNX đhuge upcomingđ
To the moonđđđđđđđ
Monday đŻ%+ incomingđĽđđđđ¤
All my followers are making bank đŚ
You all gonna be rich đ¤ |
7627 |
SYNX |
$SYNX 2.64M float with 69 months of cash on hand and war ... this has it all for a squeeze â
|
6923 |
BANL |
$BANL $4 IPO Super clean low float . Will see big move IMO |
6923 |
SYNX |
$SYNX to open above $3 IMO |
6921 |
SYNX |
$SYNX have all the slappers eyes . Undervalued and overshorted .
Squeeze watch â
|
6921 |
BANL |
$BANL If the shorts try to cover Monday early .. I'll load a lot here đ𧤠Let's gap up and squeeze them . |
6920 |
BANL |
$BANL Underpriced Oil stock with Buyback program . â
$HUSA $TPET
To squeeze again .. |
6919 |
SYNX |
$SYNX Will get slapped underpriced for what's happening . |
6919 |
HUSA |
War /oil Stocks will be hot .
$SYNX
$HUSA
$BANL
On watch for Monday |
6917 |
MSTR |
$MSTR
Bloody Mon 𩸠|
6527 |
APLD |
$BTC.X $IREN $CIFR $APLD $CORZ When you see this bullsh*t you know Iran is about to give up. BULLISH AF! |
5686 |
WULF |
$IREN $CIFR $APLD $WULF $CORZ This is correct. There may be a sell off at the open but it will be bought right up. And if there is you just F***ING BUUUUY!!! |
5683 |
CIFR |
$BTC.X $IREN $CIFR $APLD $WULF REMEMBER - Oil from the Hormuz Strait supplies:
US- 5% of America's total oil supply
China- 50% of China's total oil supply
Iran would be wrecking their ally China by closing off Hormuz. That is the last thing Iranians would want right now.
BTFD!!!!!!!!!!!!!!!!!!! |
5683 |
BBAI |
$BBAI all of the war craziness creates INCREDIBLY BULLISH LONG TERM MOMENTUM FOR BBAI!!! BTFD!!! |
5683 |
XOM |
$USO $XLE $XOM $INDO $DVN LOL only up 2.72% |
5683 |
APLD |
$BTC.X $IREN $CIFR $CORZ $APLD
98,707 was the BOTTOM.
BTFD!!!!!! |
5683 |
IREN |
$BTC.X $CORZ $IREN $CIFR $WULF Iranâs regime is trapped in a strategic chokehold: 90% of its oil flows to China via covert âdark fleetâ tankers and Shandongâs teapot refineries. Closing Hormuz would implode Tehranâs lifelineâ$150M daily from Beijingâwhile barely denting U.S. energy security. Chinaâs addiction to discounted Iranian crude props up the ayatollahs, and Tehran canât afford to sabotage its sole economic patron.
BTFD!!!!!!! |
5683 |
BBAI |
$IREN $CIFR $APLD $WULF $BBAI LMFAO look at the futures hardly down at all. Tomorrow you JUST F***ING BUUUUY! |
5683 |
OXY |
Here's a look at commodities đ
Crude oil +2.53%
Watch names like $OXY $XOM $CVX tomorrow đ˘ď¸ |
4929 |
NKE |
Nike $NKE is sitting directly on its 50 day moving average here ahead of its earnings report on Thursday after the market closes đ
Wall St. expects EPS of $0.123 and Sales of $10.71B đŚ
Implied move of 8.25% đ |
4926 |
EL |
$EL looks like next move will be to fill the gap from back in early February, back up to $80.80 |
4925 |
EL |
$EL +12.5% since this post
probably better return than most accounts trading in the same period đ¤ˇââď¸ |
4925 |
HOLO |
$HOLO No one gives a damn what you think. Youâre Yair3333âs paid fraud pumper sidekick. Youâre only here to entice people to lose more. |
3825 |
HOLO |
$HOLO And he reveals himself after his appearing for 2 weeks. No coincidence there right didnât even tag him just shows up. Hakuna Yair Donnarstag Kingsland Builder46 all one paid shill sitting in Shenzhen 𤣠|
3825 |
HOLO |
$HOLO What about the 77 other times I shorted and won not counting my current short that I'm up 75% on now. I know it's pHOToShoPped @Hakuna61 đđ |
3825 |
HOLO |
$HOLO Your credibility is ZERO. A known liar and wrong everyday since creating this account. |
3825 |
HOLO |
$HOLO They own no Bitcoin, all fake. Company is a pure fraud. |
3825 |
HOLO |
$HOLO Math and charts donât lie, bagholders and shills do. China fraud. 3 reverse splits within a year, cumulative ratio of 1:8000. Serially toxic diluted thru convertible note offerings, down -99.9% This continues lower then reverse splits again. |
3825 |
DHAI |
@It_S_Me @globaldaytraderzzzzzzz $DHAI going to 0.70 tomorrow |
3746 |
PET |
@It_S_Me @globaldaytraderzzzzzzz no its not $PET goikg into reverse split not $DHAI |
3746 |
TSLA |
$SPY X is out of control. That site is so toxic that i can't have a civilized conversation. I'm glad i have ST where people know everything about politics and economics and get along to each other. $DJT $BTC.X $TSLA |
2933 |
DJT |
$SPY All joking aside, I will happily support impeachment this time. $DJT Congress do your damn job! |
2932 |
TSLA |
$SPY 3 nuclear sites hit. What will Iranâs response be? the suspense is killing me! $DJT $BTC.X $TSLA |
2932 |
DJT |
$DJT I need a break. but there are so many memes on the internet. I can't stop! LOL $DJT |
2932 |
DJT |
$DJT $SPY |
2932 |
TSLA |
$SPY On the bright side, nobody is talking anymore about La Migra,DOGE, DEI, tariffs and Zelensky. $DJT $TSLA |
2932 |
DJT |
$SPY Trump has aged a lot since January. He looks like 85 years old. $DJT |
2932 |
HUSA |
$EONR $HUSA $INDO $RBNE $USEG
Just a discussion for those of us excited for the morningâŚ
Which oil stocks will pop the hardest this week?
Got some cash Iâm going to free up to concentrate all my powder in the oil/gas/energy sector this week. |
2703 |
HUSA |
$HUSA $INDO $RBNE Bulls are having fun tomorrow. Shorts will be destroyed! |
2579 |
SBET |
$SBET I donât even know who that Grandma person is, but she/he keeps talking trash about me every day. I donât care about anyoneâs opinion â Iâm here with the same strategy Iâve had all along with $LKNCY. Youâre day trading, the price goes up and down â I donât give a sh*t. Stay mad and keep talking trash about me, baby. |
2578 |
HUSA |
$HUSA $INDO $RBNE These stocks run based on the war news and oil price. New News happened last night so it changed to super bullish baby. Remember Iâm bipolar? 𤣠|
2578 |
HUSA |
$HUSA $USEG Oil is the play for next week ! |
2576 |
SBET |
$SBET @Grandmalikesthestock If you're good at what you do, people will follow you. If you're not, they won't. No one is forcing anyone to follow me â it just proves I'm better than you. One trade doesn't define a trader. I go long while you're day trading â two completely different strategies. You seem new to stocks, so you should take some time to learn more. I can even teach you how to swing trade and go long grandma so you can have some money for new teeth đ¤ |
2576 |
SBET |
$SBET You win some, you lose some. No one wins all the time. If you claim youâve never lost, youâre lying.
I called LKNCY at $2, OCGN at $0.23 (it ran to $20), USEG at $1.44 (it went over $3). Iâve helped change many peopleâs lives â and Iâve got the proof to back it up.
I day trade, swing trade, and go long â different strategies for different stocks. I called HUSA at $8, and it spiked to over $20.
95% of my calls are winners based on my strategy. Thatâs how I gained thousands of followers â not just a handful like you.
Plenty of your calls have been losers too. So while my followers are banking, youâre just here talking trash about me?
Sad. Stay mad, grandma. |
2576 |
SBET |
$SBET Again. I go LONGS here. Day traders can talk trash to me now but we will circle back at EOY. I called $LKNCY at $2. It went down around $1 and day traders kept talking trash to me. While I banked over $500k, day traders went silent and moved on. Now I called $SBET long again. Called OCGN at $0.23 and changed someone life. Stay Mad Grandma đ |
2576 |
SBET |
$SBET Short term might be volatile considering $ETH.X is dipping and whole crypto market is dipping too. However, I can see myself sitting 5X gains in a year. Fundamental is there. Defi is future. Chairman is ETH co-founder. SBET might be first stock on chain and crypto people can storage it in meta mask wallets. Day trader use charts. They donât know much about fundamentals. Longs care more about fundamentals. Bears are talking too much trash cause Eth is dipping. If Eth is ripping, they have no chance to talk trash. |
2576 |
SBET |
$SBET Btw, I donât think these day traders will be here at EOY to witness my gains like they went back to their basement with LKNCY. Time will tell! Now I let them keep talking trash about me. Enjoy the Sunday bulls and bears ! đ |
2576 |
USEG |
Money Monday Watchlist Pt. 2 $GNS $HCTI $USEG $BATL $MARPS This week should be fun đŚâđĽ |
2451 |
NINE |
Money Monday Watchlist Pt. 1 $HUSA $INDO $BRN $NINE $MXC This week should be fun đŚâđĽ |
2448 |
HCTI |
@Gavipoo69 yes bro mentioned $HCTI many times in my videos all the way from 0.01 until it almost hit 0.05 now currently 0.03, let's see this week đŚâđĽ https://www.youtube.com/watch?v=Thp9Id5dL88 |
2448 |
BRN |
@Takeiteasy30 I made a video on $BRN just now. must watch if you are bullish on it, thanks for the share my friend. https://www.youtube.com/watch?v=zk0kXW641cg |
2442 |
HCTI |
$GNS $HCTI $HUSA $INDO $BRN we ready for a full week of trading on these stocks and more? |
2441 |
INDO |
@LebanesePrince $INDO is in this video I just uploaded now. https://www.youtube.com/watch?v=zk0kXW641cg |
2439 |
TPET |
Also stocks I am looking at are $NINE $TPET $MARPS $BATL let me know if I missed any. |
2439 |
BRN |
New Video Out in Detail on these Stocks , Unprecedented times folks. those that are educated will capitalize $HUSA $BRN $MXC $USEG $INDO
https://www.youtube.com/watch?v=zk0kXW641cg |
2439 |
HUSA |
Oil madness watchlist pt. 1 $HUSA $INDO $USEG $BRN $RBNE |
2435 |
TPET |
Oil madnesss watchlist pt. 2 $TPET $NINE $MXC $MTR $MARPS |
2435 |
NINE |
$NINE https://www.usatoday.com/story/news/world/2025/06/22/iran-parliament-strait-of-hormuz-closure/84307368007 |
2404 |
CISS |
$CISS Shippers will be hot next week |
2357 |
ADBE |
$ADBE chart very bearish!! |
2138 |
IMRA |
@Kendrakeith @bullraging91 not quite. Both are from the same issuer, and both have the same dates; declared on 6/26, ex-div & record date on 6/27, pay date on 7/1. for both. $IMRA $IMST https://imraetf.com/ https://imstetf.com/ |
2123 |
HRL |
$HRL shameful. https://nypost.com/2025/06/21/us-news/employee-at-popular-meat-company-steals-its-secret-recipe-and-then-goes-to-work-for-competitor/ |
2108 |
AAPL |
$AAPL the highs of 2023 and 2024 are acting as support. Long tail two months ago. |
2060 |
OUST |
$OUST broke out on increasing volume. Has a chance for 2023 high around 48$. Seems to be in the right place at the right time. |
2060 |
SOFI |
$SOFI Our Great CEO!!! đ |
1779 |
NINE |
$NINE Where will you open at 4 am sweetheart? |
1715 |
ASTS |
$ASTS could be the most overlooked tech breakout of the year. Broke out through $32.50 and now grinding over $45 with volume explodingâmore than 2x average on Friday. FCC commercial license is in final review, and the LIGADO deal for premium mid-band spectrum is set to close before end of June. These are not soft catalysts. They could flip the model for global satellite coverage.
Backed by AT&T, Google, Vodafone, and American Tower (who took a board seat), this isnât a memeâitâs real tech. ASTS is building the only space-based broadband that connects directly to unmodified smartphones. No towers, no base stations, no hardware.
Short interest over 28%, institutional inflows rising, and now with a confirmed Russell 1000 inclusion. Itâs coiled for another wave if catalysts hit. $50â60+ not unrealistic.
https://www.businesswire.com/news/home/20250613700432/en/AST-SpaceMobile-Announces-Settlement-Term-Sheet-Facilitating-Long-Term-Access-to-up-to-45-MHz-of-Premium-Lower-Mid-Band-Spectrum-in-North-America-for-Direct-to-Device-Satellite-Applications |
1710 |
USEG |
Watchlist #2
Oil shock is here. Iran just moved to close the Strait of Hormuz â the most critical oil chokepoint in the world. Crude is spiking, headlines are everywhere, and small-cap energy names could explode at the open. This is the watchlist Iâm locked into Monday morning.
$EONR: U.S. oil play with Permian deal and tiny float. Now tied to one of the biggest geopolitical catalysts in years â Iran just moved to close the Strait of Hormuz. Watching $0.525 for breakout.
$USEG: Clean oil + helium name with $5M buyback, no debt, and insider control. If oil spikes again, this could squeeze fast. Breakout level is $0.375.
$JFBR: TSX approved the Fort merger, $15M deal vs $4M market cap. Low floater. $7.69 is the key breakout to watch.
$DEVS: 55% short interest on a low float, price curling off the bottom with insider ownership. $0.38 breakout could trigger a squeeze.
$GLMD: Biotech play with active PRs and Bayer synergy. Low float, and chart is coiled under $1.94 â clean setup.
Iran just made a historic move to close the Strait of Hormuz, threatening 20% of global oil supply. If crude rips at the open, we could see small-cap oil names fly. EONR and USEG are top priority setups with real catalysts and perfect charts. The rest of the list is loaded with asymmetric potential.
Hit the like if this helped â lets me know Iâm not missing anything. Final watchlist dropping in a few hours after I wrap up more research on them. Manifesting a couple runners to close out June strong. Stay tuned. |
1707 |
INDO |
Main Watchlist #1
Oilâs heating up. Biotechs are curling. And Mondayâs setup list has multiple tickers that can move 50â200% with the right volume.
đ¸ $INDO â Coiled under $5.10 breakout with Strait of Hormuz catalyst, B2 bomber headlines, and volume rotation. If oil sentiment holds, $6.97â$8.92 is in play.
đ¸ $TMDE â High borrow fee, no shares to short, and low float oil wedge breakout forming. Breakout level $1.88. Sector momentum is hot.
đ¸ $CDT â Biotech runner partnered with AstraZeneca. Chart curling on all timeframes. Needs volume over $2.49 to ignite a 30â70% move.
đ¸ $HUBC â Crypto + defense AI combo. $25M contract secured. If $2.36 reclaims with size, targets go as high as $10 with the right push.
đ¸ $NLSP â Debt-free biotech merger story, partner is Kadimastem. Coiled under $2.46 with MACD/SAR alignment. Targets: $2.64â$3.75.
Every one of these setups has a real catalyst, confirmed coil, and the potential to move big if volume hits. Keep them on radar for tomorrow. If this helped you prep early, drop a like. Letâs end the final week of June strong. Another watchlist will be added in a few hoursâstay locked in. |
1703 |
INDO |
$INDO is coiled just under $5.10 with geopolitical headlines and sector momentum lining up. Reports of U.S. airstrikes on Iranian nuclear sites, tanker disruption in the Strait of Hormuz, and RussiaâIran coordination are fueling oil sentiment. Volume rotated well Friday, and social buzz is heating up. If $5.10 breaks with size, this could rip to $5.66 then $6.97â$8.92+. One of the cleanest setups to watch for on Monday. |
1703 |
HUSA |
$HUSA $NINE https://nypost.com/2025/06/21/world-news/us-launches-strikes-on-iran-joining-forces-with-israel-days-after-trumps-tehran-warning/ |
1686 |
USEG |
$HUSA $INDO $RBNE $USEG
Thatâs it. NY Times announces another needless
War. LETS GET$$$$$$ |
1686 |
HUSA |
$HUSA $NINE $USEG https://nypost.com/2025/06/22/world-news/iran-orders-closure-of-strait-of-hormuz-putting-one-fifth-of-worlds-oil-supply-at-risk/ |
1685 |
WTI |
$PTEN $DK $WTI $NINE As I said last week , Hormuz is the elephant in the room. Parabolic movement coming. |
1681 |
FAAS |
$FAAS Our days are coming with 20F đ
âWatch FAAS heading into next weekâ |
1676 |
SHPH |
$EDHL $PTNM $SHPH all worth a watch for the upcoming week! GL đ |
1670 |
KNW |
$KNW valuation of the company will be greater than the 1,000k bitcoins IMO, when considering the USBC stablecoin and Hard Yaka portfolio holdings. Expecting more news once Greg Kidd is officially the CEO. |
1669 |
GLMD |
$GLMD is one of the most undervalued biotechs in the market trading under cash with $20M in the bank, no debt, and billion-dollar GLP-1 and fibrosis catalysts around the corner. War fear wonât derail this setup biotechs historically move on data, not geopolitics. Shorts will try to create panic, but the truth is theyâre running out of time. This is a high conviction, lower risk set up that could explode as news hits. |
1667 |
AAPL |
$XOM $XLE Oil will likely be đ 5% on Monday
Iran đŽđˇ Navy is going to close Strait of Hormuz!
$QQQ $AAPL $NVDA |
1579 |
AAPL |
$XOM $XLE Oil will likely be đ 5% on Monday
Iran đŽđˇ Navy is going to close Strait of Hormuz!
$QQQ $AAPL $SPY |
1579 |
NVDA |
$XLE Oil going Higher $XOM minimum 5+%
$QQQ $SPY $NVDA Bearish |
1579 |
AAPL |
$XOM $XLE đđđđSkyrockets Monday
$QQQ $SPY $AAPL Market Lower Dump |
1579 |
XOM |
$XOM $XLE $USO Iran strikes Israel with more missiles
$SPY $QQQ Bearish |
1579 |
XOM |
$XLE $XOM $USO Investors brace for Oil Spike/ U.S. đđ đhit â˘ď¸ sitesđŽđˇ
$SPY $QQQ Bearish |
1579 |
XOM |
$SPY Kaboom $QQQ Bearish
$XOM $XLE $USO Bullish
Iran đŽđˇ Iran orders closure of Strait of Hormuz â |
1577 |
XOM |
$USO $XOM $XLE Big Oil SQUEEZE
For those who are short / Bearish oil you will have a come to Jesus Moment
$QQQ $SPY Bearish |
1577 |
ALT |
@BioTechChap Stop making a big fuss about a study $ALT spent a ton of money on and thought was important enough to be their ADA presentation? Ok fella. Minimize something that folks here pump when it gets exposed that $ALT is a sham. Sure thing buddy.
As for muting me, doesn't bother me in the least bit. You realize how that works right? The people that mute or block me don't get to see the valuable information I share so who's the real loser in this equation.
When the Mayor speaks, people listen. |
1514 |
ALT |
@Induraman @GuruRanger And a little background. I've thought $ALT is a POS since the first call I listened to Garg and Scott try to pump snakeoil. Each bit of data that came out raised even more concerns. As I've said, the data they don't present is often as important as what they do present. My analysis has not changed, in fact it continues to get stronger by the day.
But there was a time when we all expected $ALT to PR their IND Submission by the end of the year, which would have squeezed the high short interested. As time towards the end of the year grew closer, it appeared that $ALT was a good money play...jump in, ALT releases PR, Shorts get squeezed, make money and get the eff out. There was only one problem to that...ALT never PR'd their IND submissions. Why? I have no idea. ALT was in a tailspin and the PR could have saved them from another 40% drop. This was in the midst of their PR drought following their PR blitz. So that's why I hold $ALT bags. Very simple. |
1514 |
ALT |
@Soder123 That's great but it'll never happen. Taking my Multi-vitamin and exercising is likely to have an equally effective reaponse. Obesity is dead, MASH is about to get a kick in the face and all of the other INDs $ALT is pursuing are time sinks to serve as a distraction. Appreciate the hope but reality puts this dream to bed. |
1514 |
LLY |
$ALT $XBI $LLY $NVO $VKTX
For those who are also concerned regarding Altimmune's trial data, here's the simple effect of Diet and Exercise (Lifestyle Intervention) on weight loss in $ALT's Obesity trial vs. MASH trials (to date). ALT continues to claim they aim for "meaningful weight loss" in the MASH P2b trial, but haven't provided what that means (numerically). Additionally, $ALT falsely presents 15.6% WL in presentations that involve reference to MASH and this is patently false. 15.6% is from 48-weeks of D&E driven Obesity trials, not Pemvi driven MASH trials.
@GuruRanger |
1514 |
ALT |
@Biomover The market hasn't been open since the presentations were released. It's pretty simple. Also makes more sense that $ALT has delayed the release of these presentations until non-trading hours. They are also manipulating their timing of MASH P2 readout for maximum effectiveness (possibly, least amount of decline).
To be clear, I have ZERO intension of holding through data. I have no doubts the MASH P2b data will disappoint. No doubts at all. |
1514 |
ALT |
@Obie171 @daiht1 @biorich Says the guy/lady with a J as their profile picture. I mean, come on man. Own it. You know I'm right. Challenge my profile? That's useless. I've consistently shared that I'm a shareholder and not short or playing options. It's really straight forward. You don't have to believe me though. You can be like many others than ignored me only to realize I share the most organically useful information on the $ALT board. How's this for credentials by the way? |
1514 |
ALT |
@Induraman @GuruRanger Not short. Not paid. Not pumping/bashing for a competitor. Actually an $ALT shareholder. Just more focused on presenting facts and truth than pumping hope to influence people on false pretense (which this board consistently does). |
1514 |
ALT |
@buylocellhi @Lskynrd1 I'm actually a shareholder. It disgusts me that I am. This is by far the worst investment I've ever made. Hands down. And I've had penny stocks lose 90% and those don't affect me like $ALT does. They're a scam company and I knew better. I hate to see people lied to and bullied. I believe in truth. Whether someone wants to believe it or not, it's fact and what I post is fact-based. |
1513 |
ALT |
@buylocellhi @Lskynrd1 Here's the easiest support for my posts. I KNOW that there are $ALT Bullies that Report EVERY post I make just by name. I know that @Stocktwits takes that seriously and know that ST will ask for supporting documentation if they deem it necessary. Every one of my posts is defendable because I expect the disproportionate attacks on me. $ALT Bulls salivate at the hope that I mess up. I don't mess up. They have yet to disprove anything I've shared. They block me thinking that will suppress the truth. That only prevents them from receiving valuable knowledge that they can use for their investment decisions. |
1513 |
MDGL |
$ALT $XBI $VKTX $MDGL $PFE
@Wallst45 No, this is bad for $ALT. Here's what's worse. $ALT has the data. They did the MRI-based analysis on the Placebo arm at the same time as they did the Pemvi arms and chose to never present it. It's been 570 Days since the initial Obesity P2 data was released and this is still withheld? This is a HUGE issue for $ALT. SEC/FDA type implications. Material information withheld. That's most definitely not a good thing. |
1513 |
ALT |
@Wallst45 MASH data is separate. $ALT pumps "meaningful weightloss" expected in MASH P2, but haven't quantified what that means. From previous reviews, in the MASH P1b trials, Weight Loss was ~50% less than the Obesity P2 trial for the same duration. This delta is likely attributed to the diet and exercise (lifestyle interventions) allowed in the Obesity trials. There's no word that they plan to present lean mass data as part of the MASH trials but they also hadn't planned to release it for the Obesity trial either but did 6 months post top line data.
Ultimately, this weekend's presentations supported ongoing concerns regarding $ALT cherry picking data, manipulating and massaging data, and recycling old data hoping something new would stick. This is clearly desperation by $ALT. Not a bash, but nothing else makes sense. |
1513 |
ALT |
@Alperennn @Stocktwits Your point #4 is invalid as it pertains to what I pointed out in the $ALT data/presentation as you used incorrect numbers. Conclusions based on what you entered into ChatGPT are useless as they don't represent the data that $ALT produced. |
1511 |
ALT |
@Alperennn @Stocktwits To your point #3. I pointed out data from $ALT slides and asked a question. What's wrong with that? |
1511 |
PFE |
$ALT $XBI $VKTX $MDGL $PFE
Breaking News!!!
The average weight loss in the Placebo Arm of $ALT's "Best in Class" lean mass data sub study was ~18.2 lbs!!!
ALT has NEVER presented the body composition data on this arm so their 21.9% claims were never able to put into perspective.
Why does ALT withhold this data?
1) Are they afraid it will prove that the 21.9% they are claiming isn't as impressive as they would like it to appear?
2) Are they afraid that previous concerns raised regarding the effects of Diet and Exercise (Lifestyle Interventions) on $ALT's Obesity P2 trial results would be founded?
3) Are they afraid that the Pemvi arms of the trial actually showed worse lean mass preservation than the Placebo arm?
Folks, argue all you want. Without this information, no claim $ALT makes with regards to lean mass matters. There's no context and they've withheld information.
Let that sink in before you bash people trying to help you.
Follow/Subscribe for more suggestions and perspective.
Cheers! |
1511 |
ALT |
@Alperennn No information I've shared is false. no information I've shared is done for my own gain. You realize I'm a shareholder, right? Kind breaks down your ambush.
As for the June 20th post, what are you even talking about? Do you have it? This doesn't sound like something I would say.
No market manipulation. That's just wrong, but appreciate you realizing my information is ng my posts are relevant.
I'm not sure your AI blabber. You entered the wrong information in. This is a YOU problem, not an AI problem.
As for institutional investing, you're right that they know what they're doing. The problem, it appears, is that you don't. Do you know how many institutions are short $ALT? Do you know how many also hold long positions? Do you know how many any one institution holds right now? They buy and sell regularly. A quarterly snapshot isn't always accurate.
And my followers obviously choose fact, that's why they follow me. NO ONE on this board shares facts like I do. NO ONE |
1511 |
MRK |
@Induraman @relevance How? I typed in "AUD" into the ClinicalTrials.gov to see what $ALT's AUD start date said in their official study files (see how it compared to ALT's PR date). The first one to come up was the one I posted. Was curious that someone else was working on AUD. Didn't know the drug. Didn't know the company. Didn't know the timeframe...Knew nothing, was just curious. It didn't even mention $MRK in the study description that I saw, I had to research that. The trial was impressive and gives confidence of being legit. Worth a look. Compare it to $ALT's chicken scratch while you're at it.
Truly embarrassing and further confidence that BP has NO interest in $ALT's crackerjack operation. As I'm different than the ALT Board, BP is different than ALT.
Cheers! |
1511 |
ALT |
$ALT While this board is good at pumping dreamy numbers, they often fail to answer basic questions that prove $ALT to be a scam. Why hasn't ALT PR'd they have initiated the ALD trial? They have the trial description named and uploaded into ClinicalTrials.gov and have it listed as enrolling on their website. Are they waiting until after MASH data release disappoints and they can release another carrot? Will this be followed by the Lipids IND (the 3rd of 3 they floated at the end of '24)? Hmmmmm. Seems like we've solved ALT. |
1511 |
ALT |
@oneg It really is. That's one of the biggest reasons I post what I do. The $ALT board is full of pumps and frail on content. The content that they do post is whatever they got from ChatGPT (often using leading prompts). At the end of the day, $ALT's run is over IMHO and they're trying to squeeze every last ounce out of it they can before it goes belly up. |
1511 |
ALT |
@Bosa1978 Wouldn't that volume express how concerned I am? $ALT data presented is concerning. Many on this board either can't comprehend or simply chose not to so I work towards ensuring truth is available and fluffy rhetoric doesn't distract from the issues at hand. The information I share is available for all people and should be used as they see fit. Bulls that automatically discredit my posts often find themselves scratching their heads when what I share comes to full fruition. It's not a bash. It's fact-based information and perspective.
And no short position. Large long position.
Cheers! |
1511 |
ALT |
@Daniech0514 Ok, so let's get a few things VERY clear:
1) You reference a completely different Program's trials. You are not even in the same stadium.
2) You referenced the MASH P1b Extension, which was an extension to $ALT MASH P1b. This is an entirely different program than the Obesity Program.
3) The Obesity Program P2 trial enrolled 391 subjects, of which, 151 of them did not complete the trial on the trial. A subset of the Obesity P2 trial were selected for Body Composition.
4) This subset included 67 subjects that completed the P2 trial (50 Pemvi, 17 Placebo).
Note - The subset subjects were apparently chosen before the trial began. This is suspect that a trial with an ~40% dropout rate would have 100% participant completion in the subset group.
5) MRI-based Body Composition data was generated and presented for the Pemvi (drug) group to produce a 21.9% lean mass ratio. Placebo (control) arm was never presented so no comparisons or validation could occur. |
1511 |
ALT |
@Alperennn @Stocktwits And to your claim that you responded to my posts and I reported and deleted all of your argument is curious as I don't recall ever having a conversation with you (unless it was under a different name that got banned).
Also, I suggest not making accusations about someones (my) positives if you don't know. I am not short $ALT and I am shareholder so your accusation is false. Further more, the narrative is sharing truth and fact-based evidence (from $ALT's slides/posters). Nothing fabricated, it's all there.
As for being worried about data being released Monday, not in the least bit. In fact, I'm not worried about ALT data at all. It will be here when it gets here and hopefully there will be a pump before data so I can dump my shares. I foresee a 60% decline in SP following data (might not be instantaneous, but that's what I see the net being when WS is done with it).
Nice try, but you even failed with ChatCPT. That's a new one.
Cheers! |
1511 |
ALT |
@GuruRanger I think you're missing the entire point here. It appears that you're trying to discredit something funky that $ALT did. They knowingly omitted the comparator arm of the trial, hence preventing putting their 21.9% into perspective. 21.9% is relatively meaningless in a trial where the control group data is not presented. If you can't understand that, nothing I share is going to make any sense to you. |
1511 |
ALT |
@andytran1976 @TaxEagle1040 We knew it all along. Thanks @TaxEagle1040 for turning aggressively on an $ALT Bull. Y'all are in disarray. Don't thank me for that though, I'm just the messenger, blame those that fed you BS all of this time and now you're stuck with a paper weight.
Cheers! |
1511 |
ALT |
@Swash77 @Calvary316 Fundamental error here.
1) $ALT presented that their Pemvi group of the subset achieved 21.9% lean mass ratio in WL.
2) $ALT never produced/presented lean mass ratio of the Placebo (Control) arm so 21.9% has not context because they hid the comparator group (Placebo).
3) Previous arguments on this board suggested that knowing the lean mass ratio for the Placebo (control) arm were irrelevant because they were only ~2%.
4) Per ALT's ADA presentation, WL in the Placebo arm was 8.2% which not only means lean mass dat would be relevant, it would be pertinent.
5) Omitting this data, and thus any comparisons, raises further concerns about ALT's data manipulation.
Note - This does not mean the 21.9% in the Pemvi group is insignificant, it just means there's no presented comparison so no conclusions can be made. |
1511 |
ALT |
@Alperennn @Stocktwits Your point #2. I referred to the effects on BP showing less effective over time in the Obesity and MASH trials. This was $ALT's data, not mine. Not sure where your response swerved to Weight Loss. In fact your ChatGPT response was in line with what I defended about $ALT Weight Loss data so by bashing me, you prove my point (and that I'm fair and corrected other posters who misrepresented Weight Loss data). Again, that's where we're different. |
1511 |
ALT |
@perpetbill Expert? I appreciate the compliment. And simply because I take the time to do the research. $ALT, in particular, I spend a disproportionate amount of time on because it's actually fun exposed a fraud company. Didn't start that way, but the eager liars on the board made it an enticing challenge. $ALT did not disappoint with giving me ammunition. Nuclear is just a passion and clear winner moving forward. By far one of the best energy sources and will likely continue to ramp up in the near and long term. |
1511 |
ALT |
$ALT Communicating with ALT Pumper Bullies
@newb_trdr Yeah, moreso from previous Bullies that are unsatisfied with anything that's posted. They are truly a unique and challenged bunch.
ALT Bull Basher (BB): You don't have shares
Me: I do
ALT BB: Prove it
Me: Why?
ALT BB: Because you don't have any shares
Me: I have 2,000 shares
ALT BB: No you don't
Me: Yes I do
ALT BB: Well that doesn't matter
Me: Why doesn't it matter?
ALT BB: Because you're a paid basher
Me: ???
This is what's it's like engaging with the $ALT board. |
1511 |
ALT |
The issue is that presented Lean mass data for the Pemvi arm of the Lean Mass (subset) study, but not the placebo. So $ALT claims that of the weight subjects in the Pemvi group was only 21.9% from lean mass. With no comparison arm, $ALT's claims lack context. Hypothetically, $ALT's weight loss in the Placebo arm could very well be 10% from Lean Mass, which would make any claims or $ALT lean mass hype irrelevant.
Does that make sense? |
1511 |
ALT |
@andytran1976 Only trending because of more questionable and concerning data presented by $ALT at ADA. |
1511 |
ALT |
@Bagholding_VKTX @Rcat2therescue These people just don't understand. They truly don't. But this is why so many think they know $ALT because they can ask ChatGPT something. Here's an example that probably epitomizes them:
ALT Pumper: If I bought 10,000 shares today and Altimmune gets bought out for $10B tomorrow, how much money would I have?
ChatGPT: So your 10,000 shares would be worth approximately $1.79 million in this scenario.
ALT Pumper: ChatGPT says my ALT stock is worth $1.79 million if we get bought out tomorrow.
Ey yay yay... |
1511 |
ALT |
@dcrown Which is great. Cheers for the players in the sector. I don't see $ALT being a player anymore. Them shelving their program and being stagnant for a year and a half in a white hot market speaks volumes. Garg also all but said their Program was done and they would look at Pemvi as an indirect effect. ALT Obesity is done. Period. |
1511 |
LLY |
$ALT For those who can't face reality (whether it be $ALT data concerns or my profile/position), let me help you with the latter...
A little background. I've thought $ALT is a POS since the first call I listened to Garg and Scott try to pump snakeoil. Each bit of data that came out raised even more concerns. As I've said, the data they don't present is often as important as what they do present. My analysis has not changed, in fact it continues to get stronger by the day.
But there was a time when we all expected $ALT to PR their IND Submission they said they were submitting by the end of the year ('24), which would have squeezed the high short interested. As the end of the year grew closer, it appeared that $ALT was a good money play...jump in, ALT releases PR, Shorts get squeezed, make money and get the eff out. There was only one problem to that...ALT never PR'd their IND submissions. Why? I have no idea. So that's why I hold $ALT bags. Very simple.
$VKTX $XBI $MDGL $LLY |
1511 |
ALT |
@Rcat2therescue @daiht1 As for not knowing anything that isn't already published, that's not accurate. Show me where the Placebo group in $ALT's Body Composition SubStudy had lost ~18.2lbs? I'll wait.
The point, there are many data points and $ALT picks and chooses the ones they want to share. The information can be found or extrapolated but folks on this board chose to dispute it. So what is it? I share facts and people don't like them? I only post what's published so no one should ever challenge me?
Sounds to me like you're in 100% agreement that I present only factual information. |
1511 |
ALT |
@Alperennn @Stocktwits Your Point #1. You confirm a discrepancy exists with the $ALT data. I asked a question regarding the data, you responded (assuming ChatGPT) so I'm not sure your issue here. |
1511 |
ALT |
@Rcat2therescue @Bagholding_VKTX That's where you fundamentally miss the point here. The number of shares a person holds does not add anymore credibilty to what they post or share. Research and DD is independent of share count. You have fallen into the misguided $ALT Nation falsehoods.
I'm glad that you shared this misrepresentation. |
1511 |
ALT |
@makeez @Alperennn Believe what you will. You've proven easily influenced if it fits your narrative. Group think mentality. I'm not a paid fudster. I am a shareholder. It's really that easy. All of the wild dreams and scenarios the $ALT board wants to concoct are in fact false. |
1511 |
ALT |
@Alperennn I'm not sure who you're trying to fool here but you can't even enter information correctly into ChatGPT.
Seeing this feeble attempt disappoints me because it further exemplifies how far the cognitive gap really is on this $ALT board. Typing into ChatGPT doesn't do you any good if you don't ask legitimate questions and you don't understand the answer.
And to think. You're trying to coordinate an attack on me and can't even comprehend pretty basic concepts? You are dangerous my friend. |
1511 |
ALT |
@kottijanus Oh, here's a fun fact...$ALT has ~38k followers. Whether they ignore me or not, that's 38k sets of eyes that have the opportunity to see the gold that I share. What they choose to do with that information is up to them. No skin off my back. I'm just the messenger.
Headed back to the beach. No time for the basement my friend.
Cheers! |
1511 |
MRK |
$ALT Curious, how many have looked at the AUD trial? They PR'd they had initiated it on May 19th and no one seems to care. Why? Because it's a sham. It's a useless distraction for shelving/discontinuing the Obesity Program.
Interestingly enough, for those legitimately interested in AUD, check out this impressive trial design for AUD by $MRK (and sponsored by the "National Institute on Alcohol Abuse and Alcoholism (NIAAA)"). It makes $ALT look like childsplay. I mean, seriously ALT? You look pitiful.
https://clinicaltrials.gov/study/NCT06484075?term=AUD&limit=10&sort=@relevance&rank=3 |
1511 |
ALT |
@Alperennn Why would you suggest to people report me for sharing information about what $ALT posted/presented? This is a personal attack and not warranted. @Stocktwits, please review this accounts posts (Mind you, they joined April, 2025).
To you posts, nothing deceptive. The data is directly from $ALT's presentations. Your responses are inaccurate and appear to be pulled from ChatGPT. |
1510 |
ALT |
@Calvary316 @Turribull @jmmoore4 Don't have a clue on $ALT? Think what you will but I'm not a random Bear/Short. I've done a deep dive on $ALT's data and have uncovered numerous issues. You don't have to agree, that's fine, but that doesn't change the analysis I've done and the conclusions I've come to. If you'd like to explain what you think I'm missing, I'd me more than happy to entertain it. |
1509 |
ALT |
$ALT Busted again. Seriously, what is wrong with these guys? Remember when I said it was odd that ALT didn't publish the Lean Mass data from the Placebo group and this board whined it was because the WL was so low (claiming 1-2%)...Well what's the excuse now when it was 8.2%. I'll ask the question again...why is $ALT hiding this data? It's the comparator for God's sake.
Likely explanation: Having Placebo data for their Lean Mass claims would make the 21.9% look statistically insignificant.
$XBI $VKTX $TERN $GPCR Thank you |
1509 |
ALT |
$ALT Here's a little secret. The Bull Pumpers who are in contact with Investor Relations have known for some time their trigger was going to be whether MASH P2b data was presented at ADA or not. This is why share price fizzled last week and why shorts remain so high and confident.
Simple terms: If data was good, Dr. Harris was going to present the data at ADA in a podium presentation. If it was not good, they were going to wait until after ADA and release the data the following week. This approach was chosen so they don't have to answer questions about less than optimal MASH P2b data at ADA and they would be able to start hyping their next carrot, lipids, before their MASH letdown.
Take it for what it's worth, but if the $ALT Bull Pumpers were honest, they would confirm this.
Follow/Subscribe for more information and perspective.
Cheers!
~BioRich Capital |
1509 |
ALT |
@Calvary316 @BTECHINV What's funny is that he didn't. In fact he opened the $ALT pit of data manipulation further. My analysis remains the gold standard of the $ALT board. |
1509 |
ALT |
$ALT Looks like Garg and Co. are waiting to the very end of the month so that they can get "full-value" out of Pemvi. Hmmmm, could "Full-value" = Drag shareholders along so they can tap the Shelf at higher share prices and get their smoke and mirrors gimics in place before the disappointing data drop?
Y'all should have listened. But pump on Monday so I can make more money and cover. |
1509 |
ALT |
@Fingerofinfinity @BTECHINV Absolutely not. I'm also not having a hard time understanding that they said Q1, then Q2, then late Q2, then late June. I'm fully engaged brother and stand by my observations and conclusions. And absolutely not nervous about my analysis or conclusions on $ALT but I am, however concerned about my investment and will be executing my exit strategy at the appropriate time (like many on this board will...some of the most Bullish Pumpers included). |
1509 |
ALT |
@Excessive_Directive Then why do they keep talking about it? It's been the #1 trending topic for $ALT for over a month, followed by Buyout speculation. This isn't a short thing, this is a Bull thing. Shorts could give a shit. They're making money. Longs are the ones worried. Oh, and before ALT Bulls pump Shorts are scared if they start covering, that's natural going into a data readout out. It's truly amazing they didn't cover sooner.
And ED, you're savvy enough to know this. I'm not sure why you've changed your tone lately. You definitely appear nervous, and for good reason. |
1509 |
ALT |
@Benedictus @BTECHINV Or one can conclude that Im convicted. And BTECH, nice pull from the spate account. You miscontexted my post (like many do) so your points are irrelevant.
As for $ALT doing this out in the open...they do that with everything and Bulls choose to ignore it because "they wouldn't be that dumb" or it can't be true. |
1509 |
ALT |
$ALT For all of those ALTers actually interested in facts, here are ALT's 2 Presentations from last year at ADA. Hmmmm... Looks similar, but do you see any differences or anything new?
https://ir.altimmune.com/static-files/273cedfd-ad2d-4c24-aa1a-6ad09522775a
https://ir.altimmune.com/static-files/912ee924-e705-4354-9c7b-fc6a533e62e5 |
1509 |
ALT |
@Fingerofinfinity @BTECHINV Wrong again. You continue to try and psycho-analyze me and continue to fail miserably. Let me see if I can help.
1) Altimmune the company IMHO is Gargage
2) $ALT the ticker is a highly manipulated stock with a high short interest.
3) Data has not been released yet so Wall Street games can continue (hoping they run this before data so I can get out and Shorts can destroy $ALT again for maximum profit)
Again, I believe the data will be underwhelming. How Wall Street responds is anyone's guess. "Great" data could cause this ticker to drop 50%. Remember, $ALT hasn't formally PR'd them discontinuing their Obesity Program (although it's dead) so this will be an opportunity for Wall Street to right-size ALT's share price. This will likely be followed with PTs lowering and ratings to be neutralized.
So yes, lot's of moving parts. I'm on it good buddy. That's where I'm different than this board.
Cheers! |
1509 |
ALT |
@BTECHINV And a fake scientific Bull must be relying on their back-up accounts. With regards to the timing with ADA, that was Investor Relations, not me. Also, the idea (you know this) was for the placeholder to be in place and if there was compelling data, it would have easily been provided. Remember, $ALT didn't mention they would have fun data at readout until well after the last patient completed 24-weeks.
As for your laundry list of data, maybe put into perspective how long each of these data pieces would take to gather. Your list might seem like a long time, but 4 months? Come on man, do yourself a favor and focus on fact. |
1509 |
ALT |
@DG20 This was in today's presentation. They did this sort of stuff with the "Lean Mass" data. They released it 6 months after top line data (as a sub-set), and then changed it again to reach their current 21.9%. Data harvesting, manipulation and massaging at its finest.
Fun fact about the lean mass data beyond what I mentioned above, ALL participants in the Lean Mass Data completed the trial...A trial that had an ~40% discontinuation rate. Seems legit, right?
$ALT is a master of massaging data. Simple minds are fooled (as evident on this board), brilliant minds are not (including BP).
$XBI $VKTX $IBB $LLY |
1509 |
ALT |
@Fingerofinfinity @BTECHINV While I can see where herd mentality shines here, BTech is not correct. The data should have been released already. Data delays are to maximize relevancy so the other pieces of their puzzle are in place for when they drop data. While "no one" knows the data, the company's actions scream that it won't be good.
1) $51M in dilution through mid-May, including $16M in April for between $2.75 and $5.25/share. This is also over a month from when the last patient completed 24-weeks and unknown amount of time from the first patient.
2) High interest loan for up to $100M
Both of these reason serve NO purpose if they were confident at that time that data was going to be good/and or they expected SP to rise. Ignoring this fact is reckless.
Shorts are not nervous. They haven't been. They've strategically played $ALT because ALE let them. Get made at Garg and Company, not the shorts. They may cover now because statistically data is due and they've made their money. |
1509 |
ALT |
@BTECHINV $ALT wants to get Placebo to show 7-12% vs. The 20+% they expect. They plan to do this by re-reads. The entire goal is to lower placebo numbers to show a bigger delta because they can't raise the drug response nunbers.
I've laid out in the past how important it would be to see raw data (initial data before re-reads) and cleaned up data. That would speak volumes. It would also serve as perspective for P1b data.
Either way you slice it, what's presented will not have the same level of integrity as P1b. |
1509 |
ALT |
@Daniech0514 You won't look it up because you can't look it up. Was never part of the trial. This was a specialized pet project to pump data. Remember, of the 67 chosen, ALL had completed the Obesity Phase 2 trial. The Phase 2 trial had an ~40% discontinuation rate so you tell me whether you think that data is manicured. This also the first time we're seeing that participants in the subgroup experience relative weight reduction of 8.2%. This is significantly greater than the 2.2% from the full study. Another flag. Bonus...this 8.2% is significant and will be another dagger in $ALT Obesity Program.
Just as a side note, it was 391 Subject (of which 151 did not complete the trial). |
1509 |
MDGL |
$ALT Remember this? Remember how we asked for the Placebo arm data for Lean Mass Ratio and we were told it didn't matter because Placebo was ~2% in the full trial?
Turns out this glaring omission was because the Placebo arm in the Lean Mass Subgroup had an 8.2% weight loss. This suggests that the lean mass data from the Placebo (Control) group would have produced relevant data. That relevant data would have likely diluted ALT's Lean Mass claims and not be a talking point (likely showing statistical INsignificance).
Maybe I'm missing something here. Can any Bulls help me out?
$XBI $VKTX $MDGL $PFE |
1509 |
PCSA |
$PCSA Stop with the reality check, these paid shills have a job to do and you are peeing in their Cheerios đ |
1411 |
PCSA |
$PCSA Nooo don't post a link to the lawsuit of the only drug they are activley developing! Some may read it and it may undermine the clear as day effort to promote the shares well beyond a reasonable value. Frankly it's amazing the stockk is where it is in light of the nearly 5X increase in recent market cap.
Their Nasdaq delisting extension date is soon to expire and I wonder if another reverse split will even be allowed with the new Nasdaq rules and them having done the last one in Jan 24.
Shares are down 99.7% since inception, you don't whipe out shareholder value to that degree by living up to your past promises to shareholders.
Funny thing is the two lawsuits against them are from those who were intimately involved with working with David Young. They include an ex board member, ex executive, and ex consultant. Some may suggest it telling. Just my opinons as always. Do your own DD. It's all in the public filings. Or ask good old Jerry Parker, allegedly Patrick Lin. |
1411 |
PCSA |
$PCSA Just FYI. |
1410 |
PCSA |
$PCSA The licensor of 6422, a company owned by an ex well regsrded board member and the company's ex COO, terminated the license agreement for 6422. Read the court documents and do your due diligence. |
1410 |
PCSA |
$PCSA 132. In addition to its termination of the Agreement, Elion requested that Processa
coordinate the hand back of its intellectual property and the Asset, consistent with the partiesâ
Agreement.
133. Per the License Agreement, Elionâs notice of termination took immediate effect.
134. Rather than coordinate the hand back amicably, Processa initiated its baseless lawsuit.
Curiously, Processa elected to delay filing its actual complaint for over two monthsâand only on
the final day of the allowable time to do so after Elion filed a demand for such complaint. This
timing belies Processaâs allegations that it was in any way damaged by Elionâs Termination Letter.
135. Under the partiesâ Agreement, the latest date b |
1409 |
PCSA |
$PCSA 147. Elion terminated Processaâs license to develop, manufacture, and commercialize the
Asset and related intellectual property pursuant to Sections 11.4 and 11.5 of the License Agreement
via written notice on May 7, 2024.
148. To date, Processa has not returned Elionâs Asset and related intellectual property, or
contacted Elion to coordinate the hand back of Elionâs intellectual property. |
1409 |
PCSA |
$PCSA. Blind leading rhe blind... |
1409 |
PCSA |
$PCSA "Rather than undertake reasonable, diligent, and good faith efforts that a
biopharmaceutical company of similar size and resources would normally use to fulfill its contractual obligations, as required by the partiesâ contract, Processa instead squandered this
valuable time, and, to date, has failed to complete even Phase 1B (Protocol ELC101-20) of the
clinical study in accordance with the License Agreement. Indeed, over the course of four years, Processa has barely enrolled only a handful of patients, has removed the Dose-confirmation period,
and has not successfully determined the maximum tolerated dose (âMTDâ) as contemplated by the
protocol attached to the License Agreement at the time of execution back in 2020.
77. Since May 2021, Elion has repeatedly warned Processa, both verbally and in writing,
that its dilatory and misleading actions were in violation of the License Agreement, and that Elion
did not approve of its actions. " |
1409 |
PCSA |
$PCSA The promoters working overtime. All hand on deck, Aug 4 Nasdaq delisting extension expires and odds are they may not allow the company yet another reverse split after the last one not long ago. Redchip and whoever else may have been retained, keep up the good work.
To their credit. The recent increase in valuation up about 5x is impressive considering that horribly dilutive financing, likely with good old Armistice, well known structured investor that loves thise pre paid warrants, some of which appear to be subject to a repricing, added substantially more dilution. Read the filings, its all there, inclusing multipke lawsuits. |
1409 |
TSLA |
$SPY $QQQ $NVDA $TSLA $PLTR yesssssssssssssssss yessssssssssss |
1333 |
HUSA |
$HUSA - the closure of the strait of Hormuz is epic. it is the most important oil transport choke point in the world. 20% of the worldâs oil passes through it. impact will be substantial. |
1271 |
SPCB |
$SPCB this should run tomorrow |
1262 |
TSLA |
$TSLA The launch was cool as heck. $4.25 flat fee. Love it keep it up! I used 30 bucks and had 5 successful rides. Its a game changer |
1177 |
OSCR |
$OSCR maybe we wonât get much dip after all lol
Ok 25 + this week maybe it is then lol |
1175 |
OSCR |
$OSCR pulled back a healthy $2 from highs Friday. May open slightly red because of whatâs going on, but think $25+ is possible eow |
1175 |
WBD |
$WBD in 2023, movie sales were 2.47 tickets per person per year. 70M tickets would have to sell to get to a $1.1B box office, which would only net WBD like $400M.
Which CNN can find a way to piss away in 13 weeks.
Disaster. |
1152 |
WBD |
$WBD hate that it has to happen this way, but since itâs going back to 8.50 anyway, red Monday is red Monday. |
1152 |
WBD |
$WBD tomorrow, I awake |
1151 |
WBD |
$WBD before the bombs |
1151 |
WBD |
$WBD one of the prettiest women I ever laid with was a bullâs mom |
1151 |
WBD |
$WBD the market teases, meow |
1151 |